{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-078031","form_type":"8-K","ticker":"MLTX","cik":"0001821586","company_name":"MoonLake Immunotherapeutics","filed_at":"2026-07-14T21:31:54+00:00","discovered_at":"2026-07-15T10:05:00.286585+00:00","generated_at":"2026-07-15T10:05:37.216151+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"MoonLake Immunotherapeutics raises additional $30M from underwriters' overallotment exercise","bullets":["Underwriters exercised in full their option to purchase 1,500,000 additional ordinary shares.","Gross proceeds of $30.0 million from the sale of the option shares, before underwriting discounts.","Closing of the option share issuance occurred on July 14, 2026.","The option was part of a previously announced public offering of ordinary shares and pre-funded warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-078031","json":"https://secwatch.observer/filing/0001213900-26-078031.json","markdown":"https://secwatch.observer/filing/0001213900-26-078031.md","text":"https://secwatch.observer/filing/0001213900-26-078031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1821586/000121390026078031/0001213900-26-078031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1821586/000121390026078031/ea0298054-8k_moonlake.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-15T10:05:37.216151+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}